Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

EU Regulator Backs Pfizer's BA.4/5-Adapted COVID Booster

The European Medicines Agency (EMA) on Monday recommended a COVID-19 booster designed to combat Omicron offshoots BA.4/5, days after endorsing a pair of boosters tailored to target the older BA.1 variant. The latest recommendation is for a so-called bivalent vaccine developed by Pfizer and BioNTech, which targets BA.4/5 as well…

Asharq Al-Awsat · Sep 12, 2022

EU regulator clears Pfizer-BioNTech's tweaked COVID booster

The European Medicines Agency has recommended the authorization of a tweaked booster dose of the Pfizer-BioNTech coronavirus vaccine that includes protection against two of the latest versions of omicron, as countries look to bolster their immunization programs ahead of winter

The Independent UK · Sep 12, 2022

Johnson Johnson Will Pay $300M To Women Who’ve Suffered From Pelvic Mesh Implant Complications

The settlement will help cover women's ongoing treatment for injuries caused by the mesh implants.

Pedestrian.tv · Sep 12, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Biden to announce new support for US biotech production

President Joe Biden is announcing a new initiative to encourage biotech production and research in the U.S. It's the latest move by the White House to boost domestic industry

The Independent UK · Sep 12, 2022

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…

Benzinga · Sep 9, 2022

Juul just lost a big battle

The e-cigarette company was being investigated by more than 30 states for allegedly marketing its products to youth

Salon · Sep 9, 2022

Michael Hiltzik: This life-saving drug will cost a record $2.8 million. Who will pay the price?

For the estimated 1,500 Americans suffering from a blood disorder known as beta thalassemia, the Food and Drug Administration's approval Aug. 17 of the drug Zynteglo was almost unalloyed good news.

Los Angeles Times · Sep 9, 2022

Read news from The Economist, FT, and more,
with one subscription

Junshi Biosciences Hits Revenue Roadblock Amid Covid Drug Delay

Key Takeaways: The company logged a revenue fall of 55% in the first half of the year and posted a loss of $131 million Phase 3 clinical trials for its Covid-19 oral drug wrapped up in May but the company has still not yet filed an application to market the…

Benzinga · Sep 9, 2022

Zenara launches generic version of Pfizer Covid drug Paxlovid

Sets MRP at ₹5,200 for a box of 20 Nirmatrelvir tablets, 10 tablets of Ritonavir

The Hindu · Sep 9, 2022

IRPC preparing to buy speciality polymer assets

IRPC, the petrochemical arm of national oil and gas conglomerate PTT Plc, is preparing to buy new assets in the speciality polymer manufacturing segment as it steps up efforts to earn more revenue from high-margin products.

Bangkok Post · Sep 8, 2022

Trump Ally Dr. Oz Hyped Unapproved 'Covid Cures' From Companies He Owns Shares Of

Republican Pennsylvania Senate candidate Dr. Mehmet Oz owns shares of two companies he publicly supported, touting their drugs as potential Covid-19 treatments — even though the drugs weren't approved by the U.S. Food and Drug Administration (FDA).

Benzinga · Sep 8, 2022

Losses widen at Shield Therapeutics though sales and prescriptions of its drugs grow

The maker of iron deficiency tablets says there is a huge unmet need for its products in the US were about 20 million people suffer anaemia

Birmingham Post · Sep 8, 2022

Canadian Psychedelics Company Reduces Manufacturing Time Of MDMA By Two Thirds

Nirvana Life Sciences Inc. (CSE: NIRV) announced that it has engineered a method that reduces the manufacturing time of MDMA by two thirds.

Benzinga · Sep 8, 2022

Controversial ALS drug from Amylyx gets rare second FDA meeting

Amylyx Pharmaceuticals Inc.’s controversial treatment for amyotrophic lateral sclerosis won the support of a panel of U.S. regulatory advisers, putting the product on track for likely clearance.

Tribune News Service · Sep 7, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Sep 7, 2022

HRT medicine to be sold without prescription for the first time

It is the first time women will be able to buy a certain type of hormone replacement therapy from a high street chemist without a prescription.

The Guardian - UK · Sep 7, 2022

New malaria vaccine comes a step closer as experts say it’s ‘the best yet’

Chance to eradicate diseases such as malaria could be lost and UK innovation squandered if global health investment is cut, jab co-creator tells PM

Benzinga · Sep 7, 2022

Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies

PharmaTher Holdings (OTCQB: PHRRF), the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study of its ketamine patch, KETARX, in minipigs.

The Guardian - UK · Sep 7, 2022

Government admits 50 firms were in VIP lane for test and trace contracts

Health department had denied Covid testing priority lane but new disclosure lists firms including lab behind false negatives

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Sep 7, 2022

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Pfizer’s (NYSE:PFE) lead drug GBS6 or PF-06760805 for the prevention of invasive GBS disease due to the vaccine serotypes in newborns and young infants by active immunization of their mothers during pregnancy. Pfizer shares traded in a…

Chicago Sun-Times · Sep 7, 2022

No, COVID-19 isn’t winding down, scientists say, predicting it’ll be around the rest of our lives

Even with new boosters, experts predict the scourge that’s already lasted longer than the 1918 flu pandemic will linger far into the future. Here’s why.

The Independent UK · Sep 7, 2022

ALS drug gets rare second review at high-stakes FDA meeting

The Food and Drug Administration is holding an unusual second meeting to review a closely watched drug for the illness known as Lou Gehrig’s disease

Benzinga · Sep 7, 2022

E-Cigarette Maker To Pay Over $430M To Settle Multi-State Vaping Inquiry, Cannabis Investors Need To Pay Attention

E-cigarette producer Juul Labs agreed to pay $438.5 million to 34 states and territories to sort out a two-year bipartisan investigation into its marketing and sales practices.

Benzinga · Sep 7, 2022

Mark Cuban Says 'Pharma Bro' Martin Shkreli Inspired His Cost Plus Drug Company

Billionaire investor and Dallas Mavericks owner Mark Cuban, who has revolutionized healthcare with his “Cost Plus Drug Company,” has taken inspiration from someone who is an antithesis of sorts, the Shark Tank investor revealed to Re

The Times of India · Sep 7, 2022

Unapproved antibiotic usage on rise in India; Azithromycin, cefixime most used tablets, finds study

A research study published in The Lancet has talked about one of the most serious habits of Indians which should have been talked about earlier. The study says close to 50% of the antibiotic formulations used in India's private sector in 2019 were not approved by the central drug regulator.

Birmingham Post · Sep 7, 2022

Tissue Regenix narrows losses but lingering impact of Covid weighs on healthcare market

The Leeds-based creator of regenerative medical devices increased revenues across the first half of 2022

1 … 135 136 137 138

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.